ProSTEM is led by a team of experts with a wealth of experience that focuses on the quality and services of stem cells, cells, and their metabolites and actively participates in national and international organizations, congresses, and seminars. ProSTEM also collaborates with governments and hospitals for stem cells, cells, and their metabolite development.
Andi Wijaya, Ph.D
Chairman
ProSTEM is initiated by Andi Wijaya, Ph.D., who also serves as the President Commissioner of PT. Prodia Widya Husada, Tbk. With a mission to advance regenerative medicine in Indonesia, he has established PT. Prodia StemCell Indonesia as an expansion of PT. Prodia Widyahusada, Tbk, which specializes in the storage, processing, research, and development in the field.
Andi Wijaya, Ph.D
Chairman
ProSTEM is initiated by Andi Wijaya, Ph.D., who also serves as the President Commissioner of PT. Prodia Widya Husada, Tbk. With a mission to advance regenerative medicine in Indonesia, he has established PT. Prodia StemCell Indonesia as an expansion of PT. Prodia Widyahusada, Tbk, which specializes in the storage, processing, research, and development in the field.
Andi Wijaya, Ph.D. is a scientist in clinical chemistry who has a fairly long academic profile in the history of his work. He has taught at various state universities in Indonesia. such as the Bandung Institute of Technology (ITB), Padjadjaran University (UNPAD), and has served as Head of the Postgraduate Clinical Chemistry/Biomedicine Study Program at Hassanuddin University.
Many achievements have been made in the fields of academic research and business. He received awards as a Fellow from the National Academy of Clinical Biochemistry (FACB), The National Academy of Atherosclerosis Thrombosis and Vascular Biology (FATVB), New York Academy of Science (FNAS), American Association for Clinical Chemistry (AACC), Clinical Laboratory Management Association (CLMA), Golden Academy Award from the National Academy of Clinical Biochemistry, Gold Record of Achievement in Science from NCCCA (USA), and Ganesa Widya Jasa Utama from ITB. He is also active as a member of stem cell associations such as the International Society for Stem Cell Research (ISSCR) and the International Society for Cell Therapy (ISCT).
Because of his extensive knowledge of stem cells and molecular biology, Andi Wijaya is often invited as a resource person or speaker at scientific seminars held in Indonesia. He has also been a promoter of several researchers conducting stem cell research since 2000 and is currently actively teaching at the postgraduate program at Hasanuddin University.
Dr. Cynthia R. Sartika, M.Si
Director
ProSTEM is led by Dr. Cynthia Retna Sartika, M.Si, who serves as the Director. She possesses a strong academic background in research. Her expertise in the field of research, particularly in stem cells, is unquestionable. She completed her bachelor's degree (S-1) in Biology at Universitas Padjajaran, then pursued her master's degree (S-2) in Biomedical Sciences with a concentration in Clinical Chemistry at Universitas Hasanuddin. She also obtained her doctoral degree (S-3) from the same university's Faculty of Medicine, graduating with honors (Cum Laude), and was recognized as the best PhD student of the 2006 cohort in the PhD program at Universitas Hasanuddin.
Dr. Cynthia R. Sartika, M.Si
Director
ProSTEM is led by Dr. Cynthia Retna Sartika, M.Si, who serves as the Director. She possesses a strong academic background in research. Her expertise in the field of research, particularly in stem cells, is unquestionable. She completed her bachelor's degree (S-1) in Biology at Universitas Padjajaran, then pursued her master's degree (S-2) in Biomedical Sciences with a concentration in Clinical Chemistry at Universitas Hasanuddin. She also obtained her doctoral degree (S-3) from the same university's Faculty of Medicine, graduating with honors (Cum Laude), and was recognized as the best PhD student of the 2006 cohort in the PhD program at Universitas Hasanuddin.
Her research focuses on angiogenesis in obesity,Her research focuses on angiogenesis in obesity, a condition closely associated with stem cell quality and sustainability. Her scientific contributions are evidenced by several peer-reviewed publications up to 2021, covering topics such as dental pulp stem cell differentiation, the safety of allogeneic umbilical cord MSCs, the effect of diabetic serum on MSC-derived secretome, stem cell regulatory standards in Indonesia, and the therapeutic potential of MSCs and their secretome in COVID-19.
In addition to actively participating in international stem cell congresses, Cynthia R. Sartika frequently serves as a speaker at scientific seminars in Indonesia. Between 2020 and 2021, she delivered presentations on MSC-derived extracellular vesicles, advanced MSC therapies, regulatory preparedness, and current perspectives on MSC-EVs at various national and international forums.
She is also highly active in professional organizations. Appointed by the Kementerian Kesehatan Republik Indonesia she contributed to the development of national standards for umbilical cord blood stem cell processing and storage. She is a member ISSCR and ISCTserves as Secretary General of the Indonesian Association of Atherosclerosis and Vascular Diseasesand holds leadership roles in multiple national stem cell organizations. Since 2021, she has served as a member and director of Commission III of the Stem Cell Development and Tissue Engineering Committee under the Ministry of Health, and she is also active at the regional level through the Asian Cellular Therapy Organization (ACTO)” Commission III of the Stem Cell Development and Tissue Engineering Committee under the Ministry of Health, and she is also active at the regional level through Asian Cellular Therapy Organization (ACTO).
Prof. Dr. Aw Tar-Choon, MBBS, M.Med, MRCP, FRCPE, FRCPA, FAMS, MPP
Medical Advisory
Prof. Dr. Aw Tar-Choon is an expert in medicine and clinical chemistry. He completed his medical education at the University of Malaya Medical School, followed by master at Harvard-NUS focusing on public policy. He brought his great attention to the world of regenerative medicine to jointly build the ProSTEM laboratory to become a leading cell-based therapy development laboratory.
Prof. Dr. Aw Tar-Choon, MBBS, M.Med, MRCP, FRCPE, FRCPA, FAMS, MPP
Medical Advisory
Prof. Dr. Aw Tar-Choon is an expert in medicine and clinical chemistry. He completed his medical education at the University of Malaya Medical School, followed by master at Harvard-NUS focusing on public policy. He brought his great attention to the world of regenerative medicine to jointly build the ProSTEM laboratory to become a leading cell-based therapy development laboratory.
Currently, Aw Tar-Choon serves as Medical Director at ICON Central Laboratories, Inc. and specialist doctor at Raffles Hospital & Senior Consultant in Laboratory Medicine at Changi General Hospital Singapore. Apart from his busy schedule, Aw Tar-Choon is also active in teaching at various leading universities, such as Monash University School of Medicine and National University of Singapore (NUS) Medical School. Some of the professional qualifications he has achieved include Board Certification in Internal Medicine from NUS and The Royal College of Physicians (UK), Sub-speciality Board Certification in Chemical Pathology from the Royal College of Pathologists of Australasia, member of the Royal College of Physicians (Edinburgh, Ireland), and The Academy of Medicine Singapore, the Executive Board of several world scientific institutions such as the Singapore Association of Clinical Biochemists, the Singapore Society of Pathology, and The Endocrine & Metabolic Society of Singapore.
Aw Tar-Choon is active as a expert and speaker at various scientific events in more than 21 countries to talk about topics on clinical chemistry, endocrinology, health policy, regenerative medicine, tissue engineering, and stem cells. To date, he has written more than 300 abstracts and 117 professional articles, including 12 books/book chapters on clinical chemistry, endocrinology and health policy.
Dr. dr. Dewi Wulandari, Sp.PK(K), M.Sc.
Doctor in Charge
Dr. dr. Dewi Wulandari, Sp.PK, M.Sc is take in charge of quality laboratorium in ProSTEM. She completed her general practitioner & clinical pathology specialist at the Faculty of Medicine, University of Indonesia, followed by Master's degree at Vrije Universiteit Amsterdam, majoring in Oncology.
Dr. dr. Dewi Wulandari, Sp.PK(K), M.Sc.
Doctor in Charge
Dr. dr. Dewi Wulandari, Sp.PK, M.Sc is take in charge of quality laboratorium in ProSTEM. She completed her general practitioner & clinical pathology specialist at the Faculty of Medicine, University of Indonesia, followed by Master's degree at Vrije Universiteit Amsterdam, majoring in Oncology.
She has completed his Doctoral education at the University of Indonesia with Cum Laude honors in 2022. Currently, he serves as Medical Staff at Dr. RSUP. Cipto Mangunkusumo (RSCM), Jakarta, and also the person in charge of the Prodia Stemcell Indonesia Laboratory (ProSTEM).
